导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -6.91% | 763/1050 |
| 近一周 | -2.45% | 799/1104 |
| 近一月 | -5.21% | 789/1103 |
| 近一季 | -3.25% | 401/1092 |
| 近半年 | -10.52% | 793/1070 |
| 近一年 | -4.48% | 651/1018 |
| 近两年 | 18.31% | 792/926 |
| 近三年 | 3.41% | 646/834 |
| 成立以来 | 218.90% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.86% 635/1070 |
-4.28% 776/1101 |
- - |
- - |
| 2025 | 9.98% 830/1065 |
0.32% 776/1014 |
-0.91% 759/1038 |
8.96% 864/1050 |
1.54% 342/1065 |
| 2024 | 5.21% 417/1011 |
-0.52% 342/960 |
3.29% 149/983 |
5.90% 859/991 |
-3.31% 554/1011 |
| 2023 | -8.93% 297/952 |
2.72% 467/880 |
-4.28% 477/895 |
-2.50% 179/915 |
-5.00% 501/952 |
| 2022 | -17.92% 253/867 |
-16.96% 357/773 |
6.31% 445/806 |
-10.19% 250/845 |
3.53% 261/867 |
| 2021 | 17.03% 171/740 |
2.53% 81/580 |
1.01% 533/659 |
1.36% 198/704 |
11.49% 45/740 |
| 2020 | 60.23% 193/554 |
-5.71% 309/419 |
24.37% 202/466 |
20.95% 49/517 |
12.97% 253/554 |
| 2019 | 53.20% 128/410 |
22.18% 858/1149 |
6.08% 30/1231 |
7.85% 147/390 |
9.61% 170/410 |
| 2018 | -43.92% 281/349 |
- - |
- - |
- - |
-13.92% 823/1080 |
| 2017 | -12.70% 199/285 |
- - |
- - |
- - |
- - |
| 2016 | -11.77% 74/205 |
- - |
- - |
- - |
- - |
| 2015 | 104.58% 1/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 富国城镇发展股票 VS. 东吴新产业精选股票A(580008) |